News

Some exoplanets in their stars' habitable zones may be distinctly uninhabitable due to solar flaring. Red dwarfs are known for powerful flaring, and since they're dim and their habitable zones are ...
An international team, including astronomers from Keele University, has performed a unique cosmic test to measure the mass of ...
Astronomers have spotted centimeter-sized “pebbles” swirling around two infant stars 450 light-years away, revealing the raw ...
A giant gas planet comparable in size to Saturn exists around a small red dwarf star. The discovery is beyond the scope of conventional astronomy theory, and is making experts reconsider conventional ...
Nearly 400 years ago, Galileo looked at the Pleiades star cluster through his telescope and noticed that the seven or so ...
As the country marks Matariki, more iwi are turning their gaze to Puanga – a long-overlooked star at the heart of many ...
Rigel reported net income of $11.4 million, or $0.64 basic and $0.63 diluted per share, compared to a net loss of $8.2 million, or $0.47 basic and diluted per share, for the same period of 2024.
But in common envelope evolution, “the companion star is so large that its outer layers engulf the neutron star as well,” Lorimer said. “This acts as a brake on the whole binary system.” ...
Astronomers confirmed water ice in a young star system using JWST. Crystalline water ice was found in the debris disk of star HD 181327. The star is 23 million years old and located 155 light ...
Rigel Pharmaceuticals Q1 Highlights (Rigel Pharmaceuticals) Perhaps the most impressive item to highlight is that TAVALISSE brought home $28.5M in Q1, which was a 35% year-over-year increase.
Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...